Similar articles

• Insulin analogues.

  Hirsch IB. Hirsch IB. N Engl J Med. 2005 Jan 13;352(2):174-83. doi: 10.1056/NEJMra040832. N Engl J Med. 2005. PMID: 15647580 Review. No abstract available.
• Insulin detemir--a new basal insulin analog.

  Goldman-Levine JD, Lee KW. Goldman-Levine JD, et al. Ann Pharmacother. 2005 Mar;39(3):502-7. doi: 10.1345/aph.1E334. Epub 2005 Jan 18. Ann Pharmacother. 2005. PMID: 15657117 Review.
• Insulin aspart: a review.

  Owens D, Vora J. Owens D, et al. Expert Opin Drug Metab Toxicol. 2006 Oct;2(5):793-804. doi: 10.1517/17425255.2.5.793. Expert Opin Drug Metab Toxicol. 2006. PMID: 17014395 Review.
• Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes.

  Porcellati F, Rossetti P, Ricci NB, Pampanelli S, Torlone E, Campos SH, Andreoli AM, Bolli GB, Fanelli CG. Porcellati F, et al. Diabetes Care. 2007 May;30(5):1261-3. doi: 10.2337/dc06-2208. Epub 2007 Feb 15. Diabetes Care. 2007. PMID: 17303785 No abstract available.
• ISPAD Clinical Practice Consensus Guidelines 2006-2007. Insulin treatment.

  Bangstad HJ, Danne T, Deeb LC, Jarosz-Chobot P, Urakami T, Hanas R; International Society for Pediatric and Adolescent Diabetes. Bangstad HJ, et al. Pediatr Diabetes. 2007 Apr;8(2):88-102. doi: 10.1111/j.1399-5448.2007.00233.x. Pediatr Diabetes. 2007. PMID: 17448131 No abstract available.